Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Electrophysiology equipment analyzes the electrical activity of the heart. Electrophysiology diagnostic catheters are used for temporary intracardiac sensing, recording, stimulation, and mapping. GlobalData uses proprietary data and analytics to provide a comprehensive report on the electrophysiology diagnostic catheters devices market, including market shares of different players within Japan. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the electrophysiology diagnostic catheters market in Japan was Biosense Webster followed by Abbott Laboratories, Boston Scientific, Medtronic, Siemens Healthineers and Biotronik SE & Co.
An electrophysiology diagnostic catheter includes a tube with an electrode at its end which is threaded through an artery into the heart to record electrical activity. The catheter can also emit electrical impulses and detect the heart’s response. Standard and advanced diagnostic catheters are tracked under this segment. Standard diagnostic catheters tracked are fixed and steerable diagnostic catheters. Advanced diagnostic catheters tracked are pulmonary vein loop catheters and ultrasound diagnostic catheters.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the electrophysiology diagnostic catheters devices market within Japan was expected to be over $100m in 2022.
For the latest complete market share analysis of electrophysiology diagnostic catheters device market in Japan, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
